Rudi Müller-Walz

Title: Rudi Müller-Walz: Innovator in Medicinal Formulations

Introduction

Rudi Müller-Walz is a notable inventor based in Schopfheim, Germany. He has made significant contributions to the field of medicinal formulations, holding a total of three patents. His work focuses on improving the efficacy and stability of inhalation therapies.

Latest Patents

One of his latest patents is for a dry powder for inhalation. The aim of this invention is to enhance the moisture resistance of dry powder formulations that contain a pharmaceutically ineffective carrier and a finely divided pharmaceutically active compound. The use of magnesium stearate in these formulations allows for a high fine particle dosage to be maintained even under extreme temperature and humidity conditions.

Another significant patent involves medicinal aerosol formulations. This invention utilizes a pressure-liquefied propellant mixture comprising dinitrogen monoxide and hydrofluoroalkanes. This combination improves the wetting properties of pharmaceutically active compounds, addressing formulation challenges associated with hydrofluoroalkanes. The invention also allows for better control over particle size distribution and enhances the storage stability of oxidation-sensitive active compounds.

Career Highlights

Rudi Müller-Walz is associated with Jago Research AG, where he continues to innovate in the field of medicinal formulations. His work has been instrumental in developing more effective inhalation therapies that can significantly improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Manfred Keller and Kurt Herzog, contributing to advancements in their shared field of research.

Conclusion

Rudi Müller-Walz's contributions to medicinal formulations through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the development of more effective inhalation therapies.